OBJECTIVE: To estimate the direct medical and indirect (absenteeism and short-term disability) cost burden of Crohn's Disease (CD) and Ulcerative Colitis (UC). METHODS: Data were obtained from 1999 to 2005 MarketScan databases. Twelve-month expenditures for patients with CD and UC were compared to expenditures among an equal number of propensity score matched comparison group patients. Regression analysis controlled for demographics and case-mix. RESULTS: Annual medical expenditures were significantly higher for commercially insured CD and UC patients compared to matched comparison group patients ($18,963 vs $5300 for CD patients, $15,020 vs $4982 for UC patients, respectively, all P < 0.001). Indirect costs were also high for employed patients with these conditions. CONCLUSIONS: CD and UC are costly diseases with a significant cost burden related to health care utilization and productivity loss.
OBJECTIVE: To estimate the direct medical and indirect (absenteeism and short-term disability) cost burden of Crohn's Disease (CD) and Ulcerative Colitis (UC). METHODS: Data were obtained from 1999 to 2005 MarketScan databases. Twelve-month expenditures for patients with CD and UC were compared to expenditures among an equal number of propensity score matched comparison group patients. Regression analysis controlled for demographics and case-mix. RESULTS: Annual medical expenditures were significantly higher for commercially insured CD and UC patients compared to matched comparison group patients ($18,963 vs $5300 for CDpatients, $15,020 vs $4982 for UC patients, respectively, all P < 0.001). Indirect costs were also high for employed patients with these conditions. CONCLUSIONS:CD and UC are costly diseases with a significant cost burden related to health care utilization and productivity loss.
Authors: Christopher Ma; Matthew K Smith; Leonardo Guizzetti; Remo Panaccione; Gilaad G Kaplan; Kerri L Novak; Cathy Lu; Reena Khanna; Brian G Feagan; Siddharth Singh; Vipul Jairath; Ashwin N Ananthakrishnan Journal: Clin Gastroenterol Hepatol Date: 2020-01-25 Impact factor: 11.382
Authors: Laurie Keefer; Jennifer L Kiebles; Monika A Kwiatek; Olafur Palsson; Tiffany H Taft; Zoran Martinovich; Terrence A Barrett Journal: Biol Res Nurs Date: 2011-02-28 Impact factor: 2.522
Authors: Benjamin Click; Claudia Ramos Rivers; Ioannis E Koutroubakis; Dmitriy Babichenko; Alyce M Anderson; Jana G Hashash; Michael A Dunn; Marc Schwartz; Jason Swoger; Leonard Baidoo; Arthur Barrie; Miguel Regueiro; David G Binion Journal: Inflamm Bowel Dis Date: 2016-06 Impact factor: 5.325
Authors: Stefan D Holubar; Kirsten Hall Long; Edward V Loftus; Bruce G Wolff; John H Pemberton; Robert R Cima Journal: Dis Colon Rectum Date: 2009-11 Impact factor: 4.585
Authors: María Del Pilar Martínez-Montiel; Gonzalo Jesús Gómez-Gómez; Ana Isabel Flores Journal: World J Gastroenterol Date: 2014-02-07 Impact factor: 5.742